CELL INTELLIGENCE · 肿瘤细胞治疗研究

拉丁美洲 CAR-T 治疗的可及性：障碍、缺口与前进路径

Access to CAR-T therapy in Latin America: Barriers, gaps, and pathways forward.

体内 CAR-T 疗法治疗癌症：机制、技术进展与临床转化

In Vivo CAR-T Therapy for Cancer Treatment: Mechanisms, Technological Advances, and Clinical Translation.

mRNA 疫苗在癌症免疫治疗中的应用：实体瘤和血液系统恶性肿瘤的当前进展与展望

mRNA vaccines in cancer immunotherapy: current progress and perspectives in solid tumors and hematologic malignancies.

多发性骨髓瘤的 RNA 治疗策略：从分子靶点到递送与临床转化

RNA-Based Therapeutic Strategies in Multiple Myeloma: From Molecular Targets to Delivery and Clinical Translation.

造血细胞移植或 CAR-T 细胞治疗后第一年的 SARS-CoV-2 疫苗接种：一项前瞻性、多中心、观察性研究 (BMT CTN 2101)

SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter,

这些数据支持在异基因 HCT、自体 HCT 和 CAR-T 细胞治疗后三至四个月开始接种 mRNA SARS-CoV-2 疫苗。

血液病患者中的 SARS-CoV-2 疫苗接种

Vaccination for SARS-CoV-2 in Hematological Patients.